Walgreens to Cut Costs Sharply as Drugstore Faces Challenges

Walgreens to Cut Costs Sharply as Drugstore Faces Challenges

Walgreens Boots Alliance and Verily, a healthcare company owned by Google's parent entity Alphabet, have announced a collaboration on multiple projects meant to improve chronic disease management and reduce healthcare spending.

Other institutional investors have also modified their holdings of the company. The short interest to Walgreens Boots Alliance Inc's float is 2.75%. CSat Investment Advisory L.P. bought a new stake in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $104,000. In context of long-term intentions, stock next five years earnings per share (EPS) growth estimates standing at 10.63%. Ticker's shares touched $73.29 during the last trading session after 2.90% change.Walgreens Boots Alliance, Inc. has 11.06 million shares volume, 71.09% up from normal. This is something that investor look for in all the stocks in which investor is trading and this is an important indicator to keep tabs on. Walgreens Boots Alliance Inc has a 1-year low of $59.07 and a 1-year high of $86.31. Shares of the company have performed 2.82% over the last three months and moved 1.02% over the last 12- months. Walgreens Boots Alliance, Inc. now has a market cap of $72.47B, while its P/E ratio stands at 14.86, while its P/E earnings growth sits at 0.55, with a beta of 0.76. The current EPS for the company has recorded at $4.93.

While maintaining our attention on the Technical analysis of Walgreens Boots Alliance, Inc.

Performance Review: Over the last 5.0 days, Walgreens Boots Alliance, Inc. Adjusted earnings per share were $1.46, an increase of 14.1% on both a reported and constant currency basis, compared with the same quarter a year ago.

Walgreens sales for the last quarter rose 9.9% to $33.8 billion, analysts had expected the chain to report $33.78 billion, The Wall Street Journal reports.

More notable recent Walgreens Boots Alliance, Inc.

Karl Stefanovic is leaving Today!
In a statement following the announcement, Stefanovic admitted "it's been a tough time" but thanked viewers for their support. But in the end, he said Stefanovic wanted him to express his gratitude to those who mattered most: the viewers.

However, its US pharmacy business posted a strong quarter, helping Walgreens beat profit estimates. Walgreens Boots Alliance's revenue was up 9.9% compared to the same quarter past year.

Walgreens Boots Alliance, Inc.

During the first quarter, the company declared a regular quarterly dividend of $0.44 per share.

Trading volume, or volume, is the number of shares or contracts that point towards the overall activity of a security or market for a given period. Walgreens Boots Alliance's dividend payout ratio is 29.24%. (NASDAQ:WBA) news were published by: Streetinsider.com which released: "Pre-Open Movers 12/14: (ALQA) (BEL) (GPS) Higher; (DTEA) (AXON) (WBA) Lower (more...) - StreetInsider.com" on December 14, 2018, also Nasdaq.com with their article: "Is Walgreens Boots (WBA) a Great Stock for Value Investors?"

More notable recent Walgreens Boots Alliance, Inc. In percentage terms, the aggregate Walgreens Boots Alliance, Inc. shares held by institutional investors is 65.1%. BidaskClub cut shares of Walgreens Boots Alliance from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, August 28th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and seven have assigned a buy rating to the company's stock. Barclays Capital has "Equal-Weight" rating and $80 target. BidaskClub raised shares of Walgreens Boots Alliance from a "hold" rating to a "buy" rating in a report on Wednesday, September 12th. Following the completion of the sale, the director now owns 8,207 shares of the company's stock, valued at $652,292.36. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The firm is having a distance of -2.61% form 20 day moving average, SMA 50 of -1.9% and an SMA 200 of 3.98%. The stock was sold at an average price of $79.79, for a total value of $955,086.30. KBC Group NV now owns 786,675 shares of the pharmacy operator's stock valued at $47,213,000 after acquiring an additional 52,546 shares in the last quarter.

Related Articles